Finance

Lists
Q3 2026 earnings • released • EPS met 0.00% • Revenue met 0.00%
See results
CPIX:NASDAQ
Cumberland Pharmaceuticals, Inc.
$6.01
-9.35%
(-0.62) 1D
Nov 13, 3:50:03 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CPIX...
Open
$6.58
High
$6.61
Low
$5.90
Mkt. cap
90.11M
Avg. vol.
164.90K
Volume
77.02K
52-wk high
$9.28
52-wk low
$1.85
EPS
-$0.73
Beta
0.16
Shares outstanding
14.98M
No. of employees
88
Open
$6.58
High
$6.61
Low
$5.90
Mkt. cap
90.11M
Avg. vol.
164.90K
Volume
77.02K
52-wk high
$9.28
52-wk low
$1.85
EPS
-$0.73
Beta
0.16
Shares outstanding
14.98M
No. of employees
88
News stories
From web sources and news partners
About Cumberland Pharmaceuticals, Inc.
CEO-
Employees88
Founded1999
HeadquartersNashville, Tennessee, United States
SectorHealth Care
IndustryPharmaceutical industry
Websitecumberlandpharma.com
Analyst
Recommendation
Action
Price target
Projected
Date
No analyst ratings found.
Last report
Nov 10, 2026
Fiscal period
Q3 2026
$5.07 / -
0.00%miss
Revenue / Est. (USD)
2.16M / -
0.00%miss
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
13.68M
163.85K
166.46K
2.16M
Cost of goods sold
2.24M
-
-
1.06M
Cost of revenue
2.24M
-
-
1.06M
Research and development expenses
1.55M
765.84K
772.16K
841.16K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
10.25M
2.32M
2.55M
2.18M
Operating expense
12.81M
3.10M
3.33M
3.03M
Total operating expenses
15.05M
3.10M
3.33M
4.09M
Operating income
-1.37M
-2.93M
-3.16M
-1.94M
Other non operating income
-
-
-
-
EBT including unusual items
-1.41M
-2.85M
-3.10M
-1.12M
EBT excluding unusual items
-1.41M
-2.85M
-3.10M
-1.12M
Income tax expense
23.24K
3.87K
3.87K
3.87K
Effective tax rate
-1.65%
-0.14%
-0.12%
-0.35%
Other operating expenses
-
-
-
-
Net income
-1.41M
-3.29M
-4.28M
77.78M
Net profit margin
-10.32%
-2,007.71%
-2,569.04%
3,606.87%
Earnings per share
-
-
-
-
Interest and investment income
91.97K
78.03K
60.88K
822.89K
Interest expense
-112.94K
-66.00
-724.00
-4.60K
Net interest expenses
-20.98K
77.96K
60.16K
818.28K
Depreciation and amortization charges
-
-
-
-
EBITDA
-329.31K
-1.66M
-3.12M
-1.91M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps